Get started
Amgen Inc. 4.875% 01-MAR-2053Amgen Inc. 4.875% 01-MAR-2053Amgen Inc. 4.875% 01-MAR-2053
BondBondBond

Amgen Inc. 4.875% 01-MAR-2053

OverviewProfile
Full chart

Compare with Amgen Inc. 4.875% 01-MAR-2053



Key terms


Outstanding amount
‪1.00 B‬ USD
Face value
1,000.00 USD
Minimum denomination
2,000.00 USD
Coupon
4.88%
Coupon frequency
Semi-annual
Maturity date
Mar 1, 2053
Term to maturity
26 years

Bond info


Issuer
Amgen, Inc.
Sector
Health Technology
Industry
Biotechnology
Home page
amgen.com
Issue date
Aug 18, 2022
ISIN
US031162DK36
CUSIP
031162DK3
FIGI
BBG019610KM1
Identifiers
ISIN US031162DK36
CFI code
DTFNGR
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Classification


Placement type
Maturity type
Duration type
Long-term
Issue allocation
Conversion option
Sinking fund
Ownership form

Profile


Sign up to see advanced bond data
Unlock important bond data including coupon rates, redemption details, risk assessments, and much more.